UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
(Address of principal executive offices) (Zip Code)
(
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) |
Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
| Item 5.07 | Submission of Matters to a Vote of Security Holders. |
On November 18, 2026, DeFi Capital Markets, Inc., a Maryland corporation (the “Company”) held its 2026 annual meeting of stockholders (the “Meeting”). As of October 20, 2026, the record date for the Meeting, the Company had outstanding and entitled to vote 3,028,463 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), which constitutes all of the outstanding voting capital stock of the Company.
At the Meeting, the stockholders voted on five proposals, each of which is described in more detail in the Company’s definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on October 20, 2026. At the Meeting, stockholders appointed two (2) directors, and approved proposals 2, 3, 4 and 5, each of which were presented for a vote. The tables below set forth the number of votes cast for and against or withheld, and the number of abstentions or broker non-votes, for each matter voted upon by the Company’s stockholders.
Proposal One: The election of two (2) Class I director nominees named by the Company to hold office for a term of three (3) years until the annual meeting of stockholders to be held in 2029.
| For | Against | Abstain | Broker Non-Votes | |||||||||||||
| Milton C. Ault, III | 1,657,780 | 57,079 | 987 | 434,856 | ||||||||||||
| Ronald A. Seff, M.D. | 1,579,967 | 135,216 | 663 | 434,856 | ||||||||||||
Proposal Two: The ratification of CBIZ CPAs P.C., as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
| For | Against | Abstain | Broker Non-Votes | |||||||||||
| 2,124,421 | 3,484 | 22,797 | 0 | |||||||||||
Proposal Three: The approval of an amendment of the Company’s Articles of Incorporation (the “Articles”) to authorize 25,000,000 shares of preferred stock and to permit the issuance of those 25,000,000 shares of preferred stock with rights and preferences to be determined by the Company’s Board of Directors from time to time.
| For | Against | Abstain | Broker Non-Votes | |||||||||||
| 1,582,929 | 130,478 | 2,439 | 434,856 | |||||||||||
Proposal Four: The approval of an amendment of the Articles to authorize 25,000,000 shares of class B common stock.
| For | Against | Abstain | Broker Non-Votes | |||||||||||
| 1,556,699 | 156,829 | 2,318 | 434,856 | |||||||||||
Proposal Five: The approval, for purposes of complying with Rule 713(a) of the NYSE American, the issuance by the Company of additional shares of Common Stock underlying the Company’s convertible notes issued or issuable pursuant to the amended and restated securities purchase agreement dated October 9, 2026.
| For | Against | Abstain | Broker Non-Votes | |||||||||||
| 1,699,286 | 14,373 | 2,187 | 434,856 | |||||||||||
| Item 9.01 | Financial Statements and Exhibits. |
| (d) | Exhibits: |
| Exhibit No. | Description | |
| 101 | Pursuant to Rule 406 of Regulation S-T, the cover page is formatted in Inline XBRL (Inline eXtensible Business Reporting Language). | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101). |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| DEFI CAPITAL MARKETS, INC. | |
| Dated: November 18, 2026 | /s/ Harvey B. Grossblatt |
| Harvey B. Grossblatt | |
| President and Chief Executive Officer |
3